The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography

被引:79
作者
Efrati, S [1 ]
Dishy, V
Averbukh, M
Blatt, A
Krakover, R
Weisgarten, J
Morrow, JD
Stein, MC
Golik, A
机构
[1] Assaf Harofeh Med Ctr, Dept Med A, Div Cardiol, IL-70300 Zerifin, Israel
[2] Assaf Harofeh Med Ctr, Div Nephrol, IL-70300 Zerifin, Israel
[3] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA
关键词
N-acetylcysteine; contrast media; renal failure; nitric oxide; oxidative stress;
D O I
10.1046/j.1523-1755.2003.00322.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Renal failure induced by radiographic contrast agents is a known complication of coronary angiography, especially among patients with chronic renal failure. Recently, treatment with N-acetylcysteine (NAC) has been shown to have a protective effect but the mechanisms are unknown. We examined the hypothesis that NAC protected against contrast-induced renal impairment through effects on nitric oxide metabolism and oxidative stress. Methods. Patients with a serum creatinine concentration above 106 mumol/L undergoing coronary angiography were randomly assigned to receive either NAC 1 g (N = 24) or placebo (N = 29) twice daily 24 hours before and after angiography with 0.45% saline hydration in a double-blind study. Creatinine clearance was calculated and urinary nitric oxide and F2-isoprostane excretion were measured at baseline, 24 and 96 hours after angiography. Results. Treatment with NAC significantly improved the effect of contrast media on creatinine clearance, and maximal beneficial effect was observed 24 hours after angiography. Creatinine clearance (mL/min) was 59.5 +/- 4.4, 64.7 +/- 5.8, and 58.7 + 3.9 at baseline, 24, and 96 hours after angiography in the NAC group, respectively, and 65.2 +/- 3.2, 51.5 +/- 3.7, and 53.6 +/- 3.9 in the placebo group, respectively (P < 0.0001). NAC treatment prevented the reduction in urinary nitric oxide after angiography. The urinary nitric oxide/creatinine ratio (mol/mg) was 0.0058 +/- 0.0004, 0.0057 +/- 0.0004, and 0.0052 +/- 0.0004 at baseline, 24, and 96 hours after angiography in NAC group, respectively, and 0.0057 +/- 0.0007, 0.0031 +/- 0.0005, and 0.0039 +/- 0.0005 in the placebo group, respectively (P = 0.013). NAC had no significant effect on urinary F2-isoprostanes. Conclusion. NAC treatment has renoprotective effect in patients with mild chronic renal failure undergoing coronary angiography that may be mediated in part by an increase in nitric oxide production.
引用
收藏
页码:2182 / 2187
页数:6
相关论文
共 38 条
[21]   Oxidative stress in chronic renal failure [J].
Martín-Mateo, MC ;
Sánchez-Portugal, M ;
Iglesias, S ;
de Paula, A ;
Bustamante, J .
RENAL FAILURE, 1999, 21 (02) :155-167
[22]   Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality [J].
McCullough, PA ;
Wolyn, R ;
Rocher, LL ;
Levin, RN ;
ONeill, WW .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (05) :368-375
[23]   Endothelial function hypertension - The role of superoxide anion [J].
McIntyre, M ;
Bohr, DF ;
Dominiczak, AF .
HYPERTENSION, 1999, 34 (04) :539-545
[24]  
Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233
[25]  
Morrow JD, 1999, METHOD ENZYMOL, V300, P3
[26]   The isoprostanes: Their quantification as an index of oxidant stress status in vivo [J].
Morrow, JD .
DRUG METABOLISM REVIEWS, 2000, 32 (3-4) :377-385
[27]   Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog [J].
Recchia, FA ;
McConnell, PI ;
Bernstein, RD ;
Vogel, TR ;
Xu, XB ;
Hintze, TH .
CIRCULATION RESEARCH, 1998, 83 (10) :969-979
[28]   NEPHROTOXIC RISKS OF RENAL ANGIOGRAPHY - CONTRAST MEDIA-ASSOCIATED NEPHROTOXICITY AND ATHEROEMBOLISM - A CRITICAL-REVIEW [J].
RUDNICK, MR ;
BERNS, JS ;
COHEN, RM ;
GOLDFARB, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (04) :713-727
[29]   NEPHROTOXICITY OF IONIC AND NONIONIC CONTRAST-MEDIA IN 1196 PATIENTS - A RANDOMIZED TRIAL [J].
RUDNICK, MR ;
GOLDFARB, S ;
WEXLER, L ;
LUDBROOK, PA ;
MURPHY, MJ ;
HALPERN, EF ;
HILL, JA ;
WINNIFORD, M ;
COHEN, MB ;
VANFOSSEN, DB .
KIDNEY INTERNATIONAL, 1995, 47 (01) :254-261
[30]   Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion [J].
Salom, MG ;
Ramírez, P ;
Carbonell, LF ;
Conesa, EL ;
Cartagena, J ;
Quesada, T ;
Parrilla, P ;
Fenoy, FJ .
TRANSPLANTATION, 1998, 65 (10) :1315-1321